TELO
Telomir Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.23
+9.82%Sep 14, 2026, 12:00 UTC
Telomir Pharmaceuticals announced research findings from The Ohio State University College of Veterinary Medicine showing that Telomir-Zn inhibits cell growth in human and canine osteosarcoma models.
Source: